Bukwang Pharmaceutical Co logo

Bukwang Pharmaceutical Co

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Bukwang Pharmaceutical Co provides produces oral hygienic, and pharmaceutical products.

Investor Profile

Bukwang Pharmaceutical Co has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (33%)
  • Series A (33%)
  • Series B (33%)

Country Focus

  • United States (67%)
  • Israel (33%)

Industry Focus

  • Biotechnology
  • Life Science
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bukwang Pharmaceutical Co frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 1
FutuRx
Asia, HaMerkaz, Israel, Ness Ziona
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
RB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
RM Global Partners
North America, New York, United States, New York
Co-Investments: 2
JVC Investment Partners
North America, Illinois, United States, Northbrook
Co-Investments: 1
HH
North America, California, United States, San Francisco
Co-Investments: 1
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2

What are some of recent deals done by Bukwang Pharmaceutical Co?

ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series BJan 20, 2022
Amount Raised: $139,855,923
ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series AAug 18, 2020
Amount Raised: $18,000,000
Protekt Therapeutics

Ness Ziona, HaMerkaz, Israel

Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases

BiotechnologyHealth CarePharmaceutical
Series UnknownNov 12, 2019
Amount Raised: $4,100,000